← Back to Clinical Trials
Recruiting Phase 4 NCT06380491
Melatonin's Effect on Nighttime Blood Pressure and Sleep in OSA Patients (MEBP-OSA)
Trial Parameters
Condition Obstructive Sleep Apnea of Adult
Sponsor Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 50
Sex ALL
Min Age 18 Years
Max Age 60 Years
Start Date 2023-06-22
Completion 2024-11-22
Interventions
Melatonin 3 MG Oral Tablet
Brief Summary
The goal of this clinical trial is to learn if melatonin works to treat comorbid insomnia in adults with OSA and nocturnal non-dipping blood pressure pattern. The main question it aims to answer is: Does melatonin maintain sleep during night and recover the dipping blood pressure pattern?
Eligibility Criteria
Inclusion Criteria: * Polisomnographic diagnosis of Obstructive Sleep Apnea * Non-dipping blood pressure on Ambulatory blood pressure monitoring (ABPM): Exclusion Criteria: * Use of sleep or psychiatric medication * Use of Positive Airway Pressure (CPAP or Bipap) * Neurologic or psychiatric disorder
Related Trials
NCT06430957
OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia
View Trial →
NCT06380491
Melatonin's Effect on Nighttime Blood Pressure and Sleep in OSA Patients (MEBP-OSA)
View Trial →
NCT05289063
Vascular Endothelial Dysfunction in Sleep Apnea
View Trial →